Cover Image
市場調查報告書

全球醫藥基因學市場:各技術(聚合酵素鏈鎖反應,定序,微陣列,其他),各用途(藥物研發,治療),各地區 - 趨勢與預測

Global Pharmacogenomics Market, by Technology Type, Application and Geography - Trends and Forecast to 2025

出版商 Coherent Market Insights 商品編碼 593069
出版日期 內容資訊 英文 210 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球醫藥基因學市場:各技術(聚合酵素鏈鎖反應,定序,微陣列,其他),各用途(藥物研發,治療),各地區 - 趨勢與預測 Global Pharmacogenomics Market, by Technology Type, Application and Geography - Trends and Forecast to 2025
出版日期: 2017年11月22日 內容資訊: 英文 210 Pages
簡介

本報告提供全球醫藥基因學市場相關調查,彙整市場概要和各技術,各用途,及各地區的趨勢,加入此市場的主要企業的簡介等資料。

第1章 調查目的與假設

第2章 市場概要

第3章 市場趨勢,法律規章,趨勢分析

  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 市場機會
  • 影響分析
  • 流行病學
  • 法律規章方案
  • 產業趨勢
  • PEST分析

第4章 各技術市場

  • 簡介
  • 聚合酵素鏈鎖反應
  • 定序
  • 微陣列
  • 其他

第5章 各用途市場

  • 簡介
  • 藥物研發
  • 治療
  • 腫瘤
  • 心臟
  • 疼痛管理
  • 神經疾病
  • 其他

第6章 各地區預測

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東
  • 非洲

第7章 競爭環境

  • 熱圖分析
  • 市場佔有率分析
  • 企業簡介
  • 分析師的見解

第8章 章節

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Pharmacogenomics is an essential research area for development of medication for pain, cancer, psychotropic, and cardiovascular disease. The success of this medication is possible through the use of innovative technologies that help define the dosage setting for subsets of the population and an individual’s response to a specific drug. The success of the precision medicine is possible through the application of pharmacogenomics that uses information about a person’s genes, enzyme activities, cellular environment, and proteins to diagnose and treat diseases. Rapid advancements in groups of specialized molecular diagnostic tests is contributing to the improvement for assessment of real-time treatment of diseases.

Market Dynamics

Major factors that propel the market are increasing demand for personalized drugs, increasing prevalence of several non-infectious and infectious diseases, rising utilization of these technology for effective treatment therapeutics, and growing awareness about benefits associated with pharmacogenomics. Continuous collaboration among pharmacogenomics manufacturers for various applications in clinical and translational research is also expected to drive growth of the market across regions. In 2016, Merck & Co. Inc., collaborated with Biocartis, an innovative molecular diagnostic company to develop and commercialize a new liquid biopsy technology for RAS biomarker testing. This can enable more access to the test for number of metastatic colorectal cancer patients. Furthermore, use of pharmacogenomics to perform diagnostic assays in the field of determining individual’s susceptibility to certain diseases, toxicology, biochemical genetics, and drug safety are also expected to lead to rapid growth of the market for pharmacogenomics over the forecast period.

Key features of the study:

This report provides in-depth analysis of pharmacogenomics and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, regulatory scenario, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global pharmacogenomics market based on the following parameters – company overview, financial performance, geographical presence, key developments and strategies, and future plans

Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Bayer AG, AstraZeneca plc, Assurex Health, GE Healthcare, Bristol-Myers Squibb Company, Qiagen, Inc., F. Hoffmann-La Roche Ltd, Transgenomic, Inc., Abbott Laboratories, Inc., and GlaxoSmithKline

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future type up-gradation, market expansion, and marketing tactics

The global pharmacogenomics market report caters to various stakeholders in this industry including investors, researchers, pharmacogenomics manufacturers, new entrants, and financial analysts.

Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the pharmacogenomics market.

Detailed Segmentation:

  • Global Pharmacogenomics Market, By Technology Type:
  • Polymerase Chain Reaction
  • Sequencing
  • Microarray
  • Other Technologies
  • Global Pharmacogenomics Market, By Application:
  • Drug Discovery
  • Therapeutic Application
  • Oncology
  • Cardiology
  • Pain Management
  • Neurological Disorders
  • Others
  • Global Pharmacogenomics Market, By Geography:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Technology Type:
  • Polymerase Chain Reaction
  • Sequencing
  • Microarray
  • Other Technologies
  • By Application:
  • Drug Discovery
  • Therapeutic Application
  • Oncology
  • Cardiology
  • Pain Management
  • Neurological Disorders
  • Others
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Technology Type:
  • Polymerase Chain Reaction
  • Sequencing
  • Microarray
  • Other Technologies
  • By Application:
  • Drug Discovery
  • Therapeutic Application
  • Oncology
  • Cardiology
  • Pain Management
  • Neurological Disorders
  • Others
  • Asia Pacific
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • By Technology Type:
  • Polymerase Chain Reaction
  • Sequencing
  • Microarray
  • Other Technologies
  • By Application:
  • Drug Discovery
  • Therapeutic Application
  • Oncology
  • Cardiology
  • Pain Management
  • Neurological Disorders
  • Others
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Rest of Latin America
  • By Technology Type:
  • Polymerase Chain Reaction
  • Sequencing
  • Microarray
  • Other Technologies
  • By Application:
  • Drug Discovery
  • Therapeutic Application
  • Oncology
  • Cardiology
  • Pain Management
  • Neurological Disorders
  • Others
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Technology Type:
  • Polymerase Chain Reaction
  • Sequencing
  • Microarray
  • Other Technologies
  • By Application:
  • Drug Discovery
  • Therapeutic Application
  • Oncology
  • Cardiology
  • Pain Management
  • Neurological Disorders
  • Others
  • Africa
  • By Country:
  • North Africa
  • Central Africa
  • South Africa
  • By Technology Type:
  • Polymerase Chain Reaction
  • Sequencing
  • Microarray
  • Other Technologies
  • By Application:
  • Drug Discovery
  • Therapeutic Application
  • Oncology
  • Cardiology
  • Pain Management
  • Neurological Disorders
  • Others
  • Company Profiles
  •  Thermo Fisher Scientific Inc.*
  • Company Overview
  • Technology Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Future Plans
  • Bayer AG
  • AstraZeneca plc
  • Assurex Health
  • GE Healthcare
  • Bristol-Myers Squibb Company
  • Qiagen, Inc.
  • Hoffmann-La Roche Ltd
  • Transgenomic, Inc.
  • Abbott Laboratories, Inc.
  • GlaxoSmithKline
  • “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Supply Side Drivers
    • Demand Side Drivers
    • Economic Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Epidemiology
    • Regulatory Scenario
    • Industry Trends
    • PEST Analysis

4. Global Pharmacogenomics Market, By Technology Type, 2017 - 2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017 - 2025
    • Segment Trends
  • Polymerase Chain Reaction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Microarray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Other Technologies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)

5. Global Pharmacogenomics Market, By Application, 2017 - 2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017 - 2025
    • Segment Trends
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Therapeutic Application
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)

6. Global Pharmacogenomics Market, By Regions, 2017 - 2025, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, By Regions, 2017 - 2025
  • North America
    • Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Bayer AG
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Thermo Fisher Scientific Inc.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • AstraZeneca plc
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Assurex Health
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • GE Healthcare
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Bristol-Myers Squibb Company
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Qiagen, Inc.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • F. Hoffmann-La Roche Ltd
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Transgenomic, Inc.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Abbott Laboratories, Inc.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • GlaxoSmithKline
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans

8. Section

  • References
  • Analyst Views
  • Research Methodology
  • About Us and Sales Contact

Browse 29 market data tables and 33 figures on "Pharmacogenomics Market - Global forecast to 2025".

Back to Top